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CASE REPORT
Angiomyolipoma (AML) is a common benign
renal tumor that is composed of thick-walled
blood vessels, smooth muscle, and adipose tissue,
but the malignant epithelioid variant is extremely
rare. Here, we report a case of a 78-year-old woman
who had malignant epithelioid AML with regional
lymph node metastases.
Case Report
A 78-year-old woman presented with fever and
left flank pain for 3 days. She was diagnosed with
urinary tract infection, and oral antibiotics were
given at local clinics. On admission, her fever had
subsided. Physical examination found no evidence
of tuberous sclerosis complex. Renal echo show-
ed a heterogeneously hypoechoic tumor in the
lower pole of the left kidney. Contrast-enhanced
computed tomography (CT) confirmed the pres-
ence of a heterogeneous mass occupying the lower
middle portion of the left kidney. No fat density
was discernible and renal cell carcinoma was sus-
pected. Paraaortic lymph nodes were also noted
(Figure 1). Radical nephrectomy was performed.
Pathology showed malignant epithelioid AML
with regional lymph node metastases. Grossly, the
mass measured 12.5×7.5×8.5 cm in size. On sec-
tioning, the tumor was found to be well demar-
cated. The cut surface was brown and yellowish
with focal hemorrhage and necrosis (Figure 2).
Microscopically, the tumor was composed of pre-
dominantly pleomorphic polygonal epithelioid
cells with abundant eosinophilic cytoplasm in 
a sheet or thick trabecular pattern, separated by
vascular structures. The cells had bizarre nuclei
with increased mitotic figures. Areas of necrosis
and hemorrhage associated with hemosiderin
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depositions were seen. Tumor emboli in lymphatic
or vascular spaces were discernible. Paraaortic
lymph nodes revealed metastases from the tumor
cells (Figure 3). Scanty adipose tissue and abnor-
mal blood vessels characteristic of classic AML were
found. Immunohistochemical (IHC) staining
showed that the tumor cells were melanosome-
associated protein (HMB-45) positive, but negative
for cytokeratin and smooth muscle alpha-actin
(SMA). So the pathologic diagnosis of malignant
epithelioid AML with regional lymph node metas-
tasis was made. A postoperative bone scan showed
multiple bony metastases 4 months later. The pa-
tient died of disseminated metastases (lungs and
bones) 5 months postoperatively.
Discussion
AMLs arise mainly in the kidney and almost al-
ways have a benign clinical course. The typical
AML is regarded as a benign lesion, despite the
presence of nuclear pleomorphism and mitotic ac-
tivity.1 Extension to the surrounding tissue or local
recurrence of AML is considered to be multifocal
lesions rather than metastasis.2 A rare variant of
atypical AML is described as epithelioid AML with
predominant epithelioid smooth muscle cells,
which is distinctly different from typical AML.
Among them, only sporadic cases have been re-
ported to have malignant clinical courses.3–5
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Figure 1. Contrast-enhanced computed tomography shows a
heterogeneous mass measuring 12.5×7.5×8.5cm over the
left renal lower middle portion. No fat density is discernible.
Paraaortic lymph nodes are also noted (arrow).
Figure 2. Grossly, the tumor is well demarcated with a




Figure 3. (A) Microscopically, the tumor is composed of large epitheloid cells with clear cytoplasm, eosinophilic peri-
nuclear condensations, and nuclear pleomorphism (hematoxylin & eosin, 400×). (B) Immunohistochemically, the tumor
cells show strong HMB-45 cytoplasmic reaction (ABC method, 400×).
Microscopically, epitheloid AML consists of
sheets of polygonal cells with abundant eosino-
philic cytoplasm and pleomorphic nuclei. HMB-45
immunoreactivity is a useful tool for the diagno-
sis of AML.6,7 Some reports have hypothesized that
AML is a member of the perivascular epithelioid
cell tumor family (PEComa) as an explanation
of the unique pattern of immunoreactivity that
shows the coexpression of muscle-specific actin
such as SMA and melanocytic markers such as
HMB-45 and melan-A.8 Positivity for HMB-45 and
negativity for most other markers, including cy-
tokeratin and epithelial membrane antigen, are
characteristics of PEComa.9,10 However, it is still
difficult to diagnose epithelioid AML because the
mature adipose cells and blood vessels that com-
prise typical AML are not evident.11 In our case, IHC
staining showed that the tumor cells were HMB-45
positive, but negative for cytokeratin and SMA.
Only scanty adipose tissue and abnormal blood
vessels characteristic of classic AML were found.
Limited numbers of malignant epithelioid AML
had been reported in the literature.1,3–5,12–18 A
definitive diagnosis is difficult to make preopera-
tively. Strict criteria in the diagnosis of malignant
epithelioid AMLs have not been established,
which include HMB-45-positive tumors of an 
epithelioid nature, and significant pleomorphism,
mitotic activity, and tumor necrosis.12–14 However,
not all cases with cytologic atypia correlate with
poor prognosis. The diagnosis of malignancy can
be made only by the presence of metastases. The
differential diagnosis from renal cell carcinoma
in those epithelioid AMLs with cellular atypia and
scanty fat tissue is still difficult.5,15 Sometimes,
the diagnosis of epithelioid AML can only be done
after surgery or autopsy. Some researchers have
reported that fine needle aspiration cytology with
immunostaining is helpful in the diagnosis.16
It is difficult to differentiate malignant epithe-
lioid AML from other solid renal tumors such 
as oncocytoma, renal cell carcinoma, and sarco-
matous lesions by imaging study alone. CT or
magnetic resonance imaging is most often used to
detect foci of fat, whose presence is overwhelm-
ingly characteristic of AML. However, the diagnosis
of epithelioid AML is difficult since the mature
adipose cells and abnormal blood vessels that
comprise typical AML are usually not evident in
epithelioid AML. No specific characteristics of
malignant epithelioid AML in imaging modalities
have been described in the literature.
Our patient had a more rapidly progressive
course compared with other reported cases. She
died 5 months after presentation due to dissemi-
nated metastases. There are no reliable morpho-
logic criteria of malignancy for these tumors,
other than the presence of metastasis. Kawaguchi
et al1 reported a case of renal epithelioid AML with
malignant transformation and detected p53 mu-
tations, which suggests that p53 mutation might
play a role in malignant transformation.14
According to scattered reports, the disease-
specific survival for malignant epithelioid AMLs
vary greatly. However, the prognosis in meta-
static disease is poor on average. Radical surgical
resection seems to yield a beneficial result. If 
disseminated disease is noted, adjuvant chemo-
therapy should be given. However, the response
is not so good.18
In conclusion, epithelioid AML is a rare vari-
ant of AML, which behaves aggressively. It is dif-
ficult to distinguish from renal cell carcinoma
preoperatively. We should keep in mind that 
careful interpretation of histopathologic and IHC
features are necessary to accurately classify the
tumor.
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